SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS RISPERIDONA INYECTABLE, RILPIVIRINA...
1 Lieferant beauftragt•31 Lose vergeben•37,54 Mio. € vergeben
Auftraggeber: Servicio Murciano de Salud / Espinardo, Spain
Vergebener Wert
37,54 Mio. €
Geschätzter Wert
206,14 Mio. €
Vergeben zu 18% des geschätzten Werts
Vergabedatum
20. März 2024
Gewinner
1
Vergebene Lose
31
Vergabewerte
Gesamtwert der Bekanntmachung
37,54 Mio. €
Summe der Loswerte
45,93 Mio. €
Der TED-Gesamtwert und die Werte auf Losebene stimmen nicht exakt überein.
Gewinner
Madrid, ESP
37,5 Mio. € Dieser Auftrag
22 Vergabebekanntmachungen•88 vergebene Lose•210,49 Mio. € gesamt
Vergebene Lose
| Los | Titel | Gewinner | Wert | Haupt-CPV |
|---|---|---|---|---|
| LOT-0031 | JANSSEN-CILAG, S.A. | 8,6 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0012 | JANSSEN-CILAG, S.A. | 6,4 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0003 | Nicht angegeben | 5,4 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0007 | JANSSEN-CILAG, S.A. | 5,0 Mio. € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0013 | JANSSEN-CILAG, S.A. | 2,8 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0022 | JANSSEN-CILAG, S.A. | 2,7 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0005 | Nicht angegeben | 2,7 Mio. € | Other nervous system medicinal products (33661700) | |
| LOT-0025 | JANSSEN-CILAG, S.A. | 2,6 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0030 | JANSSEN-CILAG, S.A. | 1,5 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0020 | JANSSEN-CILAG, S.A. | 1,2 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0011 | JANSSEN-CILAG, S.A. | 1,1 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0006 | JANSSEN-CILAG, S.A. | 1,0 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0019 | JANSSEN-CILAG, S.A. | 732.132 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0021 | JANSSEN-CILAG, S.A. | 650.784 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0024 | JANSSEN-CILAG, S.A. | 592.740 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0008 | JANSSEN-CILAG, S.A. | 523.990 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0028 | JANSSEN-CILAG, S.A. | 381.640 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0023 | JANSSEN-CILAG, S.A. | 366.656 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0027 | JANSSEN-CILAG, S.A. | 352.880 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0018 | JANSSEN-CILAG, S.A. | 271.160 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0001 | Nicht angegeben | 216.757 € | Antineoplastic and immunomodulating agents (33652000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0016 | JANSSEN-CILAG, S.A. | 135.580 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0017 | JANSSEN-CILAG, S.A. | 122.253 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0010 | JANSSEN-CILAG, S.A. | 106.926 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0029 | JANSSEN-CILAG, S.A. | 95.740 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0015 | JANSSEN-CILAG, S.A. | 53.331 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0009 | JANSSEN-CILAG, S.A. | 52.399 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0004 | JANSSEN-CILAG, S.A. | 41.684 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0014 | JANSSEN-CILAG, S.A. | 32.913 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0026 | JANSSEN-CILAG, S.A. | 17.644 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0033 | Nicht angegeben | — | Psycholeptics (33661500) |